Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Nutr ; 128(6): 927-33, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9614149

RESUMO

Very low protein diets result in a desensitization of hepatic cAMP signaling in rats, which is characterized by a loss of cAMP-dependent protein kinase (PKA) activity and type I regulatory subunit (RI). Here we have tested whether more moderate protein restriction (Trial 1) or energy restriction (Trial 2) also modulates hepatic PKA quantity and activity. In trial 1, weanling rats were allowed free access to diets containing normal protein (15%, AL-NP), moderately restricted protein (12.5%, AL-MP) and low protein (7.5%, AL-LP); in trial 2, rats were allowed free access to diet containing 15% (AL-NP) or 0.5% protein (very low protein, AL-VLP) or were energy restricted by pair-feeding a diet isonitrogenous to AL-NP but at 65% of the energy intake (ER-IN) for 14 d. Body weights were lower (P < 0.05) by d 14 in all restricted groups compared with the AL-NP group. The quantity of cytosolic RI was lower (P < 0.05) in AL-LP and AL-VLP, but not in AL-MP or ER-IN, compared with AL-NP. In contrast, there was no effect of diet on RI in the particulate fraction. RII was not changed by moderate and low protein diets in either the cytosol or particulate fraction. However, type II regulatory subunit (RII) was greater in the cytosol of ER-IN and in the particulate fraction of AL-VLP (P < 0.05) compared with AL-NP. Specific activity of PKA was lower in the cytosol and particulate fraction (P < 0.05) in the AL-VLP and ER-IN groups compared with the AL-NP group. In contrast, specific activity of PKA was maintained in cytosol from AL-LP, but lower in the particulate fraction (P < 0.05) compared with AL-NP. In summary, protein restricted-diets lower RI subunit in the cytosol; however, only in rats fed very low protein diets is this loss of RI associated with lower cytosolic PKA activity. In contrast, energy restriction lowers PKA activity in the cytosol and particulate fractions, independent of signficant reduction in RI or RII subunits. Taken together, these data indicate that moderate protein and energy restrictions have differential effects on activity and quantity of PKA.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Proteínas Alimentares/farmacologia , Ingestão de Energia , Fígado/enzimologia , Animais , Proteína Quinase Tipo II Dependente de AMP Cíclico , Proteínas Alimentares/administração & dosagem , Masculino , Ratos , Ratos Wistar , Frações Subcelulares/enzimologia , Distribuição Tecidual , Aumento de Peso/efeitos dos fármacos
3.
Agents Actions ; 7(2): 225-30, 1977 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-70988

RESUMO

The anomalous cardiac stimulation by tolazoline (2-benzyl-2-imidazoline), and alpha-adrenergic blocking agent, appears to result from the release of histamine and catecholamines. These responses can be blocked by metiamide and propranolol, respectively. It is probably that tolazoline also releases acetylcholine from the guinea pig atria. The direct effect of tolazoline on chronotropic activity of atrial pairs after blockade appears to be depressant at high concentrations, and this decrease in rate, below control levels, is not blocked by atropine.


Assuntos
Liberação de Histamina/efeitos dos fármacos , Miocárdio/metabolismo , Norepinefrina/metabolismo , Tolazolina/farmacologia , Animais , Atropina/farmacologia , Feminino , Cobaias , Frequência Cardíaca/efeitos dos fármacos , Histamina/farmacologia , Técnicas In Vitro , Masculino , Metiamida/farmacologia , Contração Miocárdica/efeitos dos fármacos , Norepinefrina/farmacologia , Propranolol/farmacologia , Coelhos , Reserpina/farmacologia , Fatores de Tempo
4.
Am J Physiol ; 230(4): 1168-72, 1976 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-4981

RESUMO

Cerebroventricular perfusion with artificial cerebrospinal fluid containing 10(-5) M ouabain was performed in adult dogs in order to describe the time course of the cardiovascular effect of intraventricular ouabain and to evaluate treatments to eliminate the cardiovascular effect. The central effect of ouabain caused a 56% increase in blood pressure above control values and a 35% increase in heart rate with various cardiac arrhythmias. Both alpha- and beta-adrenergic blocking drugs given intravenously.altered the pressure and rate effects ou ouabain, whereas vagotomy attenuated the effect.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Ouabaína/farmacologia , Antagonistas Adrenérgicos alfa/farmacologia , Antagonistas Adrenérgicos beta/farmacologia , Animais , Cães , Feminino , Injeções Intraventriculares , Masculino , Ouabaína/administração & dosagem , Fatores de Tempo , Vagotomia
6.
J Iowa Med Soc ; 62(2): 55, 1972 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-5008698
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA